1. Home
  2. SVRA vs CGNT Comparison

SVRA vs CGNT Comparison

Compare SVRA & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • CGNT
  • Stock Information
  • Founded
  • SVRA N/A
  • CGNT 2020
  • Country
  • SVRA United States
  • CGNT Israel
  • Employees
  • SVRA N/A
  • CGNT N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • CGNT Computer Software: Prepackaged Software
  • Sector
  • SVRA Health Care
  • CGNT Technology
  • Exchange
  • SVRA Nasdaq
  • CGNT Nasdaq
  • Market Cap
  • SVRA 427.3M
  • CGNT 743.4M
  • IPO Year
  • SVRA N/A
  • CGNT N/A
  • Fundamental
  • Price
  • SVRA $2.60
  • CGNT $8.59
  • Analyst Decision
  • SVRA Buy
  • CGNT Hold
  • Analyst Count
  • SVRA 6
  • CGNT 3
  • Target Price
  • SVRA $8.83
  • CGNT $8.25
  • AVG Volume (30 Days)
  • SVRA 784.8K
  • CGNT 261.7K
  • Earning Date
  • SVRA 03-18-2025
  • CGNT 04-08-2025
  • Dividend Yield
  • SVRA N/A
  • CGNT N/A
  • EPS Growth
  • SVRA N/A
  • CGNT N/A
  • EPS
  • SVRA N/A
  • CGNT N/A
  • Revenue
  • SVRA N/A
  • CGNT $339,818,000.00
  • Revenue This Year
  • SVRA N/A
  • CGNT $13.67
  • Revenue Next Year
  • SVRA N/A
  • CGNT $6.92
  • P/E Ratio
  • SVRA N/A
  • CGNT N/A
  • Revenue Growth
  • SVRA N/A
  • CGNT 12.16
  • 52 Week Low
  • SVRA $2.26
  • CGNT $6.21
  • 52 Week High
  • SVRA $5.61
  • CGNT $11.12
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 46.02
  • CGNT 38.60
  • Support Level
  • SVRA $2.26
  • CGNT $8.48
  • Resistance Level
  • SVRA $2.91
  • CGNT $9.48
  • Average True Range (ATR)
  • SVRA 0.14
  • CGNT 0.41
  • MACD
  • SVRA -0.00
  • CGNT -0.14
  • Stochastic Oscillator
  • SVRA 52.67
  • CGNT 19.17

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About CGNT Cognyte Software Ltd.

Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.

Share on Social Networks: